Search research articles
Contact Us
Filters
Showing results (11-20 of 19) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 19 results.
Nederlands Tijdschrift Voor Geneeskunde
|
April 27, 2005
[Three infants with constipation and muscular weakness: infantile botulism]
Y Thomasse, J P Arends, P A van der Heide, et al.
Nederlands Tijdschrift Voor Geneeskunde
|
September 19, 2007
[18 years experience with mechanical ventilation in patients with Duchenne muscular dystrophy]
A F Meinesz, G Bladder, J F Goorhuis, et al.
Neuromuscular Disorders : NMD
|
September 5, 2002
Quantitative assessment of calf circumference in Duchenne muscular dystrophy patients
E A C Beenakker, J de Vries, J M Fock, et al.
Neurogenetics
|
October 22, 2005
A novel 3-bp deletion in the PANK2 gene of Dutch patients with pantothenate kinase-associated neurodegeneration: evidence for a founder effect
P Rump, H H Lemmink, C C Verschuuren-Bemelmans, et al.
European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society
|
October 13, 2000
Mild axonal neuropathy of children during treatment for acute lymphoblastic leukaemia
H A Reinders-Messelink, T W Van Weerden, J M Fock, et al.
Neurogenetics
|
January 25, 2016
A heritable form of SMARCE1-related meningiomas with important implications for follow-up and family screening
E H Gerkes, J M Fock, W F A den Dunnen, et al.
Journal of Neuromuscular Diseases
|
November 19, 2016
Forty-Five Years of Duchenne Muscular Dystrophy in The Netherlands
J C van den Bergen, H B Ginjaar, A J van Essen, et al.
American Journal of Medical Genetics. Part A
|
August 11, 2020
Biallelic loss of function variants in SYT2 cause a treatable congenital onset presynaptic myasthenic syndrome
Sandra Donkervoort, Payam Mohassel, Lucia Laugwitz, et al.
American Journal of Human Genetics
|
August 2, 2020
De Novo and Bi-allelic Pathogenic Variants in NARS1 Cause Neurodevelopmental Delay Due to Toxic Gain-of-Function and Partial Loss-of-Function Effects
Andreea Manole, Stephanie Efthymiou, Emer O'Connor, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 19) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 19 results.
Nederlands Tijdschrift Voor Geneeskunde
|
April 27, 2005
[Three infants with constipation and muscular weakness: infantile botulism]
Y Thomasse, J P Arends, P A van der Heide, et al.
Nederlands Tijdschrift Voor Geneeskunde
|
September 19, 2007
[18 years experience with mechanical ventilation in patients with Duchenne muscular dystrophy]
A F Meinesz, G Bladder, J F Goorhuis, et al.
Neuromuscular Disorders : NMD
|
September 5, 2002
Quantitative assessment of calf circumference in Duchenne muscular dystrophy patients
E A C Beenakker, J de Vries, J M Fock, et al.
Neurogenetics
|
October 22, 2005
A novel 3-bp deletion in the PANK2 gene of Dutch patients with pantothenate kinase-associated neurodegeneration: evidence for a founder effect
P Rump, H H Lemmink, C C Verschuuren-Bemelmans, et al.
European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society
|
October 13, 2000
Mild axonal neuropathy of children during treatment for acute lymphoblastic leukaemia
H A Reinders-Messelink, T W Van Weerden, J M Fock, et al.
Neurogenetics
|
January 25, 2016
A heritable form of SMARCE1-related meningiomas with important implications for follow-up and family screening
E H Gerkes, J M Fock, W F A den Dunnen, et al.
Journal of Neuromuscular Diseases
|
November 19, 2016
Forty-Five Years of Duchenne Muscular Dystrophy in The Netherlands
J C van den Bergen, H B Ginjaar, A J van Essen, et al.
American Journal of Medical Genetics. Part A
|
August 11, 2020
Biallelic loss of function variants in SYT2 cause a treatable congenital onset presynaptic myasthenic syndrome
Sandra Donkervoort, Payam Mohassel, Lucia Laugwitz, et al.
American Journal of Human Genetics
|
August 2, 2020
De Novo and Bi-allelic Pathogenic Variants in NARS1 Cause Neurodevelopmental Delay Due to Toxic Gain-of-Function and Partial Loss-of-Function Effects
Andreea Manole, Stephanie Efthymiou, Emer O'Connor, et al.
Page
of 2